v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04613271 |
Full text link
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : March 11, 2023, 8 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : March 11, 2023, 8 p.m. Source : ClinicalTrials.gov |
Not reported |
Registration date
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-11-03 |
Recruitment status
Last imported at : March 11, 2023, 8 p.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
inclusion criteria: adult patients 18 years - 59 years confirmation of covid-19 based on the results of the real time pcr (rtpcr) examination for sars-cov-2 less than 7 days before the first day of taking the drug patients with mild-moderate clinical manifestations were admitted to the hospital designated by the physician according to the operational definition of the study protocol have not received covid-19 antiviral therapy consciously and voluntarily participate in research |
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m. Source : ClinicalTrials.gov |
pregnant and lactating women allergy history to favipiravir and standard hospital drugs patients with uric acid examination values above normal male> 7 mg / dl; women> 5.7 mg / dl patients with a history of prolonged ecg / arrhythmia / qt disorders cannot swallow drug |
Number of arms
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Ina-Respond |
Inclusion age min
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
59 |
Countries
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Indonesia |
Type of patients
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Mild/moderate disease at enrollment |
Severity scale
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2: Mild/moderate disease at enrollment |
Total sample size
Last imported at : March 11, 2023, 8 p.m. Source : ClinicalTrials.gov |
130 |
primary outcome
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Clinical improvement measured by no sign & symptom for 3 days and RTPCR negative |
Notes
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Nov. 4, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 1508, "treatment_name": "Azithromycin+favipiravir", "treatment_type": "Antibiotics+antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 165, "treatment_name": "Azithromycin", "treatment_type": "Antibiotics", "pharmacological_treatment": "Pharmacological treatment"}] |